Silvercrest Asset Management’s Teladoc Health TDOC Stock Holding History

Silvercrest Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,740	Closed	-$348K	–	876
2020 Q4	$348K	Sell	1,740 -710	-29%	-$144K	﹤0.01%	694
2020 Q3	$537K	Buy	2,450 +20	+0.8%	+$4.24K	﹤0.01%	597
2020 Q2	$464K	Sell	2,430 -42	-2%	-$7.36K	﹤0.01%	614
2020 Q1	$383K	Sell	2,472 -1,411	-36%	-$164K	﹤0.01%	592
2019 Q4	$325K	Sell	3,883 -92	-2%	-$7K	﹤0.01%	651
2019 Q3	$269K	Buy	+3,975	New	+$262K	﹤0.01%	652

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $39.8M AUM 27.89% 1-Year Est. Return

Silvercrest Asset Management's TDOC Position: Q1 2021 in Review

Silvercrest Asset Management sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 1,740 shares — an estimated $348K sold.

Silvercrest Asset Management first reported a position in TDOC in Q3 2019 and held it in 6 quarters. The position peaked at $537K in Q3 2020. 890 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

Silvercrest Asset Management reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
Silvercrest Asset Management sold 1,740 Teladoc Health shares in Q1 2021, an estimated $348K.
Silvercrest Asset Management first reported a position in Teladoc Health in Q3 2019 and held it in 6 quarters.
Silvercrest Asset Management's Teladoc Health position peaked at $537K in Q3 2020.
890 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Silvercrest Asset Management's 13F filing for Q1 2021, filed 17 May 2021.